The exploratory analaysis for the efficacy and safety of Rikkunshito for appetite loss during the treatment with PEG-IFN and ribaviri
Phase 4
- Conditions
- chronic hepatitis C
- Registration Number
- JPRN-UMIN000003731
- Lead Sponsor
- Department of Gastrointestinal Medicine, Chiba University Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
Not provided
Exclusion Criteria
(1)post gastrectomy (2)Use of other Kampo medicine (3)Gastrointestinal bleeding, ilues, perforation of gut
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method